Optical CT Technology Evaluated as Adjunct to Mammography for Women with Dense Breasts

A revolutionary new imaging technology has been designed using laser computed-tomography (CT) to aid in the detection and management of breast cancer.

The CT laser mammography (CTLM) system, developed by Imaging Diagnostic Systems, Inc. (Fort Lauderdale, FL, USA), a manufacturer of laser optical breast cancer imaging systems, is a breast imaging system that utilizes patented continuous wave laser technology and computer algorithms to create three-dimensional (3D) images of the breast. The procedure is non-invasive, painless, and does not expose the patient to ionizing radiation or painful breast compression.

CT laser mammography is designed to be used in conjunction with mammography. It reveals information about blood distribution in the breast and may visualize the process of angiogenesis, which usually accompanies tumor growth. The company is currently conducting a US clinical trial on the use of CTLM as an adjunct to mammography in patients with dense breasts. The clinical trial is part of the company's effort to seek US Food and Drug Administration (FDA) Premarket Approval (PMA) of the system.

Among the work-in-progress applications the company is working on includes optical fluorescence imaging, assessing the status of presurgical breast cancer chemotherapy treatment compared to magnetic resonance imaging (MRI), and the potential of using laser optical techniques to aid in categorizing types of ductal carcinoma in situ (DCIS).


Related Links:
Imaging Diagnostic Systems